SUMMARY We have postulated that the catecholamine-synthesizing enzymes tyrosine hydroxylase (TH), dopamine /3-hydroxylase (DBH), and phenylethanolamine N-methyltransferase (PNMT) are coded for by similar genes. To analyze the structural relationship of genes coding for these enzymes, we have cloned DNAs complementary (cDNA) to DBH and PNMT messenger RNAs (mRNAs). Using hybrid selection analysis to identify the cDNA clones positively, we discovered cross-hybridization between DBH cDNA clones and PNMT mRNA and between PNMT cDNA clones and DBH mRNA. Further analysis by RNA blot hybridization revealed that (1) the DBH cDNA probe hybridized predominantly to a 5500 nucleotide mRNA and less strongly to a 1100 nucleotide species, and (2) the PNMT cDNA probe hybridized strongly to the 1100 nucleotide mRNA and weakly to the 5500 nucleotide message. DNA blot hybridization analysis demonstrated that DBH and PNMT cDNA probes hybridized to several common restriction fragments of total cellular DNA. The evidence presented here suggests the existence of homologous gene-coding regions in DBH and PNMT cDNAs. These homologies may be the result of duplication of a common ancestral gene. DNA blot analysis suggests that these enzymes are coded for by single genes, which may be located in close proximity to each other in the DNA, and points to the existence of either a single gene or linked genes coding for all catecholamine enzymes. T HE classical catecholamine biosynthetic pathway described by Blaschko 1 (Figure 1 ) involves the activity of four enzymes: (1) tyrosine hydroxylase (TH), which catalyzes the first step in the pathway of the conversion of tyrosine to L-dopa; (2) aromatic L-amino acid decarboxylase (AADC), which catalyzes the conversion of L-dopa to dopamine; (3) dopamine )3-hydroxylase (DBH), which converts dopamine to norepinephrine; and (4) phenylethanolamine N-methyltransferase (PNMT), the last enzyme in the chain, which catalyzes the biosynthesis of epinephrine from norepinephrine.
T HE classical catecholamine biosynthetic pathway described by Blaschko 1 (Figure 1 ) involves the activity of four enzymes: (1) tyrosine hydroxylase (TH), which catalyzes the first step in the pathway of the conversion of tyrosine to L-dopa; (2) aromatic L-amino acid decarboxylase (AADC), which catalyzes the conversion of L-dopa to dopamine; (3) dopamine )3-hydroxylase (DBH), which converts dopamine to norepinephrine; and (4) phenylethanolamine N-methyltransferase (PNMT), the last enzyme in the chain, which catalyzes the biosynthesis of epinephrine from norepinephrine.
For the past 15 years we have been studying the regulation of enzymes that synthesize the catecholamines in the central and peripheral nervous systems. We have purified and raised antibodies against TH, DDC, DBH, and PNMT from catecholamine-contain-ing cells.
1 " 8 Immunochemical and biochemical procedures have been used to measure changes in amounts and turnover rates of these enzymes. 3 9~14 In catecholamine neurons and adrenal medulla we have found that various factors change the rate of synthesis of the enzymes in a coordinated fashion," 12 which suggests that closely related mechanisms control the regulation of the genes coding for these enzymes.
Two examples may be cited. It has long been known that the activity of TH and DBH can be increased in response to nerve impulse activity or by the administration of drugs in sympathetic ganglia, noradrenergic neurons of the locus ceruleus, or in chromaffin cells of the adrenal medulla (where PNMT as well as TH and DBH is regulated). This enzyme-induction phenomenon is studied most easily after administration of the drug reserpine. We have demonstrated that after reserpine administration, the increase of TH and DBH in noradrenergic neurons of the locus ceruleus is due to accumulation of more enzyme protein 9 and is a consequence of the increase in the relative rate of biosynthesis of these enzymes (rate of enzyme synthesis/rate of the total protein synthesis).
l0 A similar reduction of TH and DBH also can be initiated in cells of the locus ceruleus after axonotomy." The reversible reduction of enzyme activity, which occurs after damage to axons and lasts from 14 to 21 days, is identical for the two enzymes and in both instances is caused by a relative reduction in the rate of their biosynthesis.
12
On the other hand, an important feature of the catecholamine biosynthetic pathway is that all four enzymes are not expressed together in all cells. Although all four are expressed in neurons or chromaffin cells that synthesize epinephrine, in neurons, ganglia, or chromaffin cells that synthesize norepinephrine, PNMT is not expressed. In cells that produce dopamine as their final neurotransmitter, neither DBH nor PNMT is present. Based on the classical one-gene-forone-enzyme hypothesis, these facts would suggest that separate genes code for each enzyme and that these genes probably are independently regulated. Thus, one would predict from this concept that neurons and cells that contain still other combinations of the catecholamine biosynthetic enzymes should exist. That this may be the case has been suggested by recent studies in our laboratory that identified neurons in the CNS that contain only PNMT -without DDC, TH, or DBH (Ross, C. et al., unpublished observations) -and other neurons of the CNS that contain DDC alone. 15 These results suggest that the phenotypic expression of catecholamine-synthesizing enzymes in neurons and chromaffin cells may be regulated independently and that one cell type can express a single catecholamine enzyme. Alternatively, when more than one enzyme is expressed in a catecholamine cell type, the reduction or induction of their synthesis occurs in a linked, coordinated fashion.
We have recently reported our preliminary results on the existence of similar protein domains in the primary structure of these enzymes, and postulated that these enzymes probably are coded for by genes that contain similar coding sequences.
In the present studies we analyze the structural relationship of genes coding for these enzymes and present evidence for the existence of homologous gene-coding regions. The present results suggest that the catecholamine-synthesizing enzymes may be coded for by genes that have evolved through duplication of a common ancestral precursor. Elucidation of the molecular mechanisms involved in the formation of a common gene-coding sequence(s) for the catecholamine-synthesizing enzymes will provide valuable insight into the process by which neurons have evolved to express the dopaminergic, noradrenergic, and adrenergic phenotype.
Methods

Purification and Production of Antibodies to Catecholamine-Synthesizing Enzymes
The catecholamine-synthesizing enzymes TH, DBH, and PNMT were purified and antibodies against purified enzymes were raised in rabbits as described elsewhere. 8 The molecular weight of each enzyme was determined by sodium dodecyl sulfate polyacrylamide gel electrophoresis. The mass of TH, DBH, and PNMT was 60, 75, and 31 kilodaltons respectively. It is known that when TH is treated with trypsin for a short period of time (10-30 minutes at room temperature), a smaller (35 kilodalton) species can be obtained. This trypsin-digested form of TH (tTH) usually has higher specific activity than does the native form of TH.
Antibodies to each enzyme, including tTH, do not cross react with any other protein except their own antigen in crude, partially purified or purified enzyme preparations. 8 No cross-reactivity with other catecholamine-synthesizing enzymes has been demonstrated by immunohistochemistry and immunochemical precipitation.
In Vitro mRNA Translation and Enzyme Immunoprecipitation Polyribosomal [poly(A)]mRNA was purified from bovine adrenal medulla and the mRNA was translated in vitro in a reticulocyte lysate translation system as GENES FOR THE CATECHOLAMINE CELLS/Joh et al.
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described previously.
7 -l4 Total bovine adrenal mRNA was isolated as described by Seeburg et al." Immunoprecipitation of catecholamine enzymes from in vitro poly(A)mRNA translation products was carried out by the procedures detailed in our previous publications.
7 -
Synthesis of Complementary DNA Phenylethanolamine N-methyltransferase mRNA was purified by immunoprecipitation of bovine adrenal medullary polyribosomes with affinity-purified PNMT antibodies, followed by oligodeoxythymidylate cellulose column chromatography. 16 Synthesis of PNMT cDNA has been described elsewhere. 16 Sucrose-gradient-enriched DBH mRNA was used as a template for the synthesis of double-stranded cDNA with the reaction conditions of Ohno et al. 18 Tailing of double-stranded cDNA and pBR 322, transformation, and cDNA clone identification were detailed elsewhere. 16 Phenylethanolamine N-methyltransferase or DBH enzyme plasmid DNA was nick translated to specific activities of 1 to 2 x 10 8 dpm/mg as described previously. 16 
Blot Hybridization
For RNA blot hybridization, poly(A)mRNA was denatured at 50°C for 1 hour in 1 M glyoxal, 50% DMSO, and 10 mM sodium phosphate (pH 7.0) and subjected to agarose gel electrophoresis. 18 The glyoxylated RNA was transferred to nitrocellulose filters. 18 Baking, hybridization, and washing of the filters were carried out as described elsewhere. 19 For DNA blot hybridization, high-molecular-weight DNA was isolated from crude bovine adrenal nuclei as described by Blin and Stafford. 20 DNA was digested with appropriate restriction enzymes according to the conditions suggested by the manufacturer. DNA gels were stained for 20 minutes in 1 /ng/ml ethidium bromide and photographed under ultraviolet illumination. The gels were then processed essentially as described by Wahl et al. 21 The filter was hybridized as described above for RNA blot hybridization.
Results
Cross-Reactivity of Antibodies with mRNA Translation Products
Antibodies raised against tTH reacted predominantly with a 31-kilodalton protein identical in size to PNMT (Figure 2) . When an antibody raised against the native form of rat adrenal TH was used, coprecipitation of a small amount of a 72-kilodalton protein in addition to the 60-kilodalton TH was observed ( Figure  2 ). This 72-kilodalton protein was identical in size to the protein subunit precipitated with DBH antibody. In addition, bovine PNMT antibody coprecipitated a small amount of a 60-kilodalton protein identical in size to TH (Figure 2 ).
Cross-Hybridization of DBH and PNMT mRNA
Identification of DBH and PNMT clones was carried out by hybrid selection procedures detailed elsewhere. 16 While carrying out hybrid selection analysis with suspected DBH cDNA clones, the PNMT cDNA clone 22 was used as an internal control. Unexpectedly, this PNMT cDNA clone 22 appeared to hybridselect an mRNA that coded for a 72-kilodalton protein.
After immunoprecipitation with DBH antibody, it became apparent that PNMT clone 22 hybrid-selected DBH mRNA in addition to PNMT mRNA.' 7 Furthermore, DBH clones significantly cross-hybrid-selected PNMT mRNA. 
. Sodium dodecylsulfate potyacrylamide gel electrophoresis fluorograph of bovine adrenal medulla poty(A)mRNA translation products immunoprecipitated with catecholamineenzvme antibodies. MW = molecular weight; S = molecular weight standard; T = total translation product; nt = antibodies to native form oftyrosine hydroxylase (TH); tt = trypsin-digestedformofTH; rp = antibodies to rat adrenal phenylethanolamine N-methyltransferase (PNMT); bp = antibodies to bovine adrenal PNMT. Note: (I) nt coprecipitates 72-kiIodaltons protein identical in size to dopamine fi-hydroxylase, (2) tt predominantly precipitates 31 -kilodalton protein identical in size to PNMT, and (3) bp precipitates predominantly the 31-kilodalton protein but cross-reacts with a 60-kilodalton protein, identical in size to TH.
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RNA Blot Hybridization Chronic-phosphate-P-32-labeled PNMT cDNA probe 22 and DBH probe 71 were used for hybridization with poly(A)mRNA bound to nitrocellulose. PNMT probe 22 hybridized to an mRNA from bovine adrenal medulla of approximately 1100 nucleotides, with hybridization conditions described in the Methods section. Under slightly less stringent hybridization conditions, the PNMT probe hybridized weakly to an mRNA of unknown specificity with 5500 nucleotides. 17 When DBH probe 103 was used as a probe in RNA blot hybridization, an mRNA of approximately 5500 nucleotides was produced, which was identical in size to the cross-hybridizing mRNA species found when PNMT cDNA probe 22 was used under less stringent conditions.
DNA Blot Hybridization
High-molecular-weight DNA (> 30 kilobase) isolated from bovine adrenal medulla, was digested with various restriction enzymes and the digests were dispersed on agarose gels and then transferred to nitrocellulose. The filters were hybridized with DBH cDNA probe 71; the results are shown in Figure 3 . It can be seen that the probe hybridized to one to two bands per lane. Comparison of DBH and PNMT DNA blots are shown in the same figure. Phenylethanolamine Nmethyl transferase cDNA probe 22 hybridized to a 4.2 kilobase molecular-weight band found with the DBH cDNA probe. In addition, PNMT 22 hybridized to a 14 kilobase £coRI DNA band, which is identical in molecular weight to the top EcoRI band, which hybridized to the DBH 71 probe.
Discussion
The establishment of mRNA-dependent in vitro translation assay and immunoprecipitation of the enzyme protein from mRNA translation products revealed that the catecholamine enzymes TH, DBH, and PNMT share common antigenic sites when they are in the form of newly translated polypeptide chains before any posttranslational modification has occurred. The common antigenic determinants may reflect similarities in specific portions of their primary or folded structures as they exist immediately after release from the ribosome.
It has been demonstrated in our laboratory that the antibodies to TH, DBH, and PNMT are highly specific in their ability to recognize soluble or immobilized antigen in vivo. 8 Indeed, these antibodies have been used for immunocytochemical localization of the specific catecholamine enzymes expressed in dopaminergic and noradrenergic as well as adrenergic cell types with no demonstrated cross-reactivity.
Cross-reactivity of the catecholamine enzyme antibodies with in vitro synthesized enzymes may be understood if one considers the inherent nature of the polyclonal antibodies produced against these enzymes as well as the posttranslationally unmodified state of the in vitro translated enzyme. For example, because only active enzyme is injected for antibody produc- tion, the majority of the antibodies will recognize antigenic sites present on enzyme molecules as they exist in their tertiary, posttranslationally modified, and catalytically active conformation. A major antigenic site present on a catalytically active posttranslationally modified enzyme may be buried or unexposed in vivo on a second enzyme. When both are translated in vitro the buried antigenic site becomes exposed through lack of posttranslational modification and the antibody to one enzyme now cross reacts with a second enzyme. The first evidence for nucleic acid sequence homology between the catecholamine enzymes DBH and PNMT was obtained from hybridization selection experiments. 17 In addition to hybridizing predominantly to mRNA coding for DBH, several DBH clones specifically cross-hybridized to a small amount of mRNA coding for PNMT. Similarly, the PNMT clone 22, while selecting mostly PNMT message, also hybridized to a small but significant amount of mRNA coding for DBH. That cDNA probes specific for each enzyme cross hybridized on RNA blots and co-hybrid-selected both DBH and PNMT mRNA from total adrenal medulla mRNA' 7 strongly suggests that regions of homology exist in the nucleic acid sequences as well as in the primary protein structure.
There are several similar findings in the literature. 22 " 25 For example, with amino acid sequence analysis, homologous sequences have been identified in members of a bacterial catabolic enzyme pathway known as the /3-ketoadipate pathway. 25 These enzymes, like the catecholamine enzymes, catalyze very different reactions (e.g., isomerization, hydrolysis, hydroxylation, and decarboxylation), yet this amino acid sequence analysis suggests a common ancestral origin.
The catecholamine enzyme genes may indeed have followed a similar pattern of evolution, which consisted of duplication of an ancestral gene, followed by divergent evolution with conservation of sequences essential for catalytic activity, substrate and cofactor binding, and so on, to produce the unique enzyme functionalities.
Comparison of DNA blots performed with DBH and PNMT probes revealed that both cDNA probes hybridized to several common restriction fragments in paired restriction enzyme digests of bovine adrenal medulla DNA (Figure 3 ). For example, a 4.2 kilobase BamHl fragment was hybridized to both by PNMT and DBH cDNA probes. Both probes also hybridized to a 14 kilobase EcoRl fragment. These common restriction fragments could be completely different gene segments of similar size or the result of cross-hybridization of the two cDNA probes with homologous regions present in each gene.
Finally, if these common-sized restriction fragments are indeed the same DNA segment, the possibility exists either that these enzyme genes are linked or that these enzymes are each coded for by a colinear gene segment that can differentially or coordinately produce DBH and PNMT enzyme mRNA.
In conclusion, the evidence presented suggests the existence of homologous gene-coding regions in PNMT and DBH cDNAs. These homologies may be the result of duplication of a common ancestral gene. DNA blot analysis suggests that the two enzymes are coded for by single genes, which may be located in close proximity to each other in the DNA, and points to the possible existence of either a single gene or linked genes coding for the catecholamine enzymes PNMT and DBH.
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